OncoSil Medical (ASX:OSL) Cash per Share: A$0.15 (As of Dec. 2025)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

OncoSil Medical Ltd ASX:OSL

48 GF Score

Price A$1.38

GF Value A$2.90

Valuation Possible Value Trap

4 Warning Signs

View Full Analysis

What is OncoSil Medical Cash per Share?

OncoSil Medical ASX:OSL -1.79% 48 Cash per Share is A$0.15 as of Dec. 2025. GuruFocus rates ASX:OSL with a GF Score™ of 48/100 and a GF Value™ of A$2.90 (Possible Value Trap). The stock has 4 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). OncoSil Medical's Cash per Share for the quarter that ended in Dec. 2025 was A$0.15.

OncoSil Medical (ASX:OSL) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

OncoSil Medical Cash per Share Related Terms

OncoSil Medical Cash per Share Historical Data

* Premium members only.

The historical data trend for OncoSil Medical's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSil Medical Cash per Share Chart

OncoSil Medical Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Cash per Share

Get a 7-Day Free Trial

4.66

3.50

1.81

0.54

0.36

OncoSil Medical Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Cash per Share	Get a 7-Day Free Trial															0.93	0.54	0.73	0.36	0.15

48GF Score

OncoSil Medical Ltd ASX:OSL

Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

OncoSil Medical Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

OncoSil Medical's Cash per Share for the fiscal year that ended in Jun. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	5.11	/	14.30
	=	0.36

OncoSil Medical's Cash per Share for the quarter that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	2.855	/	18.92
	=	0.15

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of A$0.15 mean?

OncoSil Medical (ASX:OSL) has a Cash per Share of A$0.15 as of Dec. 2025. Cash per share is the per-share value of a company's available cash. View historical data for OncoSil Medical and its competitors.

Is OncoSil Medical's Cash per Share too high?

OncoSil Medical's current Cash per Share is A$0.15. Overall, OncoSil Medical has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does OncoSil Medical's Cash per Share compare to ABT and SYK?

OncoSil Medical's Cash per Share of A$0.15 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Medical Devices & Instruments company?

A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for OncoSil Medical and its competitors. OncoSil Medical's current Cash per Share is A$0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is OncoSil Medical stock overvalued right now?

Based on GuruFocus' analysis, OncoSil Medical (ASX:OSL) is currently considered Possible Value Trap. The stock's GF Value™ is A$2.90, compared to a current price of A$1.38 — trading 52.6% below its estimated fair value. The current Cash per Share is A$0.15. OncoSil Medical's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For OncoSil Medical (ASX:OSL), the current Cash per Share is A$0.15 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OncoSil Medical (ASX:OSL) Overvalued in 2026?

Based on GuruFocus' analysis, OncoSil Medical stock appears to be undervalued. The current stock price of A$1.38 is trading 52.6% below its estimated GF Value™ of A$2.90. GuruFocus considers OncoSil Medical to be Possible Value Trap.

Key valuation signals for ASX:OSL:

Cash per Share: A$0.15
GF Value™: A$2.90 vs. price of A$1.38 (52.6% below fair value)
GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the ASX:OSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OncoSil Medical Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies ASX:MEM ASX:CQT ASX:MX1 ASX:IPD ASX:AT1 ASX:CVB ASX:EYE ASX:ADR ASX:CSX ASX:CBL ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Address 7 Eden Park Drive, Level 5, Macquarie Park, Sydney, NSW, AUS, 2113

Website https://www.oncosil.com

OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand.

48GF Score

Get the complete analysis for ASX:OSL

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.38

Price

A$2.90

GF Value

View ASX:OSL Analysis

See Cash per Share data for all stocks →